Cyclodestructive procedures for refractory glaucoma

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 3, 2019, Pages

  Chen, Monica F ^a   Kim, Carole H ^a   Coleman, Anne L ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT;

ANALGESIA; BEST CORRECTED VISUAL ACUITY; CLINICAL EFFECTIVENESS; DISEASE CONTROL; DISEASE SURVEILLANCE; DRUG EFFECT; ENDOSCOPIC SURGERY; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; INTRAOCULAR PRESSURE; LASER COAGULATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTORY GLAUCOMA; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT PLANNING; ADVERSE DEVICE EFFECT; AQUEOUS HUMOR; CILIARY BODY; DRUG THERAPY; ENDOSCOPY; GLAUCOMA DRAINAGE IMPLANT; META ANALYSIS; PROCEDURES; SOLID STATE LASER; VISUAL ACUITY;

AQUEOUS HUMOR; CILIARY BODY; ENDOSCOPY; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANTS; HUMANS; INTRAOCULAR PRESSURE; LASER COAGULATION; LASERS, SOLID-STATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VISUAL ACUITY;

EID: 85026435047     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012223.pub2     Document Type: Review

References (90)

1. Aquino MC, Barton K, Tan AM, Sng C, Li X, Loon SC, et al., Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology 2015; 43 (1): 40-6. 10180994
2. Lima FE, Magacho L, Carvalho DM, Susanna R Jr, Avila MP,. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma 2004; 13 (3): 233-7. 10180996
3. Lima FE, Magacho L, Guimaraes N, Avila M, Susanna R,. A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science 2003; Vol. 44: ARVO E-Abstract 4294. 10180997
4. Shields MB, Wilkerson MH, Echelman DA,. A comparison of two energy levels for noncontact transscleral neodymium-YAG cyclophotocoagulation. Archives of Ophthalmology 1993; 111 (4): 484-7. 10180999
5. Ulbig M, McHugh DA, Hamilton PA,. A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology 1992: Abstract 135. 10181001
6. Ulbig MW, McHugh DA, McNaught AI, Hamilton PA,. Clinical comparison of semiconductor diode versus neodymium: YAG non-contact cyclo photocoagulation. British Journal of Ophthalmology 1995; 79 (6): 569-74. 10181002
7. Youn J, Cox TA, Herndon LW, Allingham RR, Shields MB,. A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology 1998; 126 (5): 640-7. 10181004
8. Agarwal HC, Gupta V, Sihota R,. Evaluation of contact versus non-contact diode laser cyclophotocoagulation for refractory glaucomas using similar energy settings. Clinical and Experimental Ophthalmology 2004; 32: 33-8. 10181006
9. Alves Júnior AD, Yamane R, Motta MM,. Comparative study of diode transscleral cyclophotocoagulation associated or not with periphery retinal ablation in neovascular glaucoma [Estudo comparativo da ciclofotocoagulação transescleral pelo laser de diodo associada ou não à ablação simultânea da retina periférica no gaucoma neovascular]. Revista Brasileira de Oftalmologia 2003; 62 (8): 578-88. 10181008
10. Benitez Del Castillo Sanchez J, Benitez del Castillo JM, Morales Lopez MD, Rodriguez Suarez AH,. Refractory glaucoma treatment cyclophotocoagulation vs trabeculectomy with mitomycin. Archivos de la Sociedad Espanola de Oftalmologia 1996; 70 (3): 279-88. 10181010
11. Bloom PA, Clement CI, King A, Noureddin B, Sharma K, Hitchings RA, et al., A comparison between tube surgery, ND:YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma. BioMed Research International 2013; Vol. 2013: 371951. [DOI: 10.1155/2013/371951 ] 10181012
12. Bloom PA, Noureddin BN, Sharma K, Hitchings RA, Khaw PT,. A matched comparison between tube surgery, Nd:YAG and diode laser cyclophotocoagulation in the management of refractory glaucoma. American Academy of Ophthalmology 1996: Abstract 174. 10181013
13. Brooks AM, Dallison IW, Gillies WE, Guest CS, Taylor HR,. Comparison of cycloablation with Nd:YAG cyclophotocoagulation and cyclocryotherapy. Investigative Ophthalmology and Visual Science 1993; 34 (4): 738 ARVO Abstract 182. 10181015
14. Chalam KV, Lin N, Tripathi R,. Advanced neovascular glaucoma: pars plana modified Baerveldt implant versus Nd:YAG transscleral cyclophotocoagulation. American Academy of Ophthalmology 1999: Abstract 241. 10181017
15. Chalam KV, Malkani SM, Tripathi RC, Ambati J,. Neovascular glaucoma: pars plana Baerveldt implant vs Nd:YAG transscleral cyclophotocoagulation vs YAG endocyclophotocoagulation. American Academy of Ophthalmology 2001: Abstract 168. 10181019
16. Chen JP, Wang R, Xu HY, Zhang P, Zhang J,. Clinical observation of two operation methods for neovascular glaucoma. International Eye Science 2013; 13 (11): 2259-61. 10181021
17. Cyrlin N, Tressler CS, Rosenshein JS, Dubay HB,. Contact diode laser cyclocoagulation: a long term comparison of shorter-duration; higher-power vs. longer-duration, lower-power treatment in uncontrolled glaucoma. Investigative Ophthalmology and Visual Science 1999; Vol. 40: ARVO E-Abstract 1431. 10181023
18. Egbert PR, Fiadoyor S, Budenz D, Shields MB,. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Evidence-Based Eye Care 2001; 2 (4): 238-9. 10181025
19. Egbert PR, Fiadoyor S, Budenz DL, Dadzie P, Byrd S,. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Archives of Ophthalmology 2001; 119 (3): 345-50. 10181026
20. Fankhauser F, Kwasniewska S, England C, Dürr V,. Diode versus Nd:YAG laser for cyclodestructive procedures. Ophthalmic Surgery 1993; 24 (8): 566-7. 10181028
21. Goldenberg-Cohen N, Bahar I, Ostashinski M, Lusky M, Weinberger D, Gaton DD,. Cyclocryotherapy versus transscleral diode laser cyclophotocoagulation for uncontrolled intraocular pressure. Ophthalmic Surgery, Lasers and Imaging 2005; 36 (4): 272-9. 10181030
22. Kaushik S, Pandav SS, Jain R, Bansal S, Gupta A,. Lower energy levels adequate for effective transcleral diode laser cyclophotocoagulation in Asian eyes with refractory glaucoma. Eye 2008; 22 (3): 398-405. 10181032
23. Koraszewska-Matuszewska B, Leszczyński R, Samochowiec-Donocik E, Nawrocka L,. Cyclodestructive procedures in secondary glaucoma in children. Klinika Oczna 2003; 106 (1-2 Suppl): 199-200. 10181034
24. Korte P, Wirbelauer C, Haberle H, Pham DT,. Cyclophoto-versus cyclocryo-coagulation for treatment of secondary glaucoma. Ophthalmologe 2002; 99 (Suppl 1): S97. 10181036
25. Liu G, Tang GL,. Effect of transscleral diode laser cyclophotocoagulation and cyclocryosurgery in treatment of severe glaucoma. International Journal of Ophthalmology 2008; 8 (8): 1673-4. 10181038
26. Marcus C, Moster M, Wilson R,. A four year follow up comparison of 180° vs. 360° neodymium:yag transscleral cyclophotocoagulation. Investigative Ophthalmology and Visual Science 1992; Vol. 33: ARVO E-Abstract 2876. 10181040
27. Miller-Meeks M, Higginbotham EJ,. Comparing energy levels of contact Nd:YAG transscleral laser cyclophotocoagulation (CTLC) in uncontrolled glaucoma. American Academy of Ophthalmology 1994: Abstract 130. 10181042
28. Noureddin BN, Wilson-Holt N, Lavin M, Jeffrey M, Hitchings RA,. Advanced uncontrolled glaucoma. Nd:YAG cyclophotocoagulation or tube surgery. Ophthalmology 1992; 99 (3): 430-7. 10181044
29. Radax U, Menapace R, Rigal K, Papapanos P, Amon M,. A comparison of CW Nd-YAG contact transcleral hemicyclophotocoagulation and hemicyclocryotherapy in uncontrolled primary open angle glaucoma. Spektrum der Augenheilkunde 1992; 6 (5): 228-31. 10181046
30. Shukla M, Thakkur N,. A comparative evaluation of cyclocryotherapy, cyclodiathermy and cycloanemization in glaucoma. Indian Journal of Ophthalmology 981; 29 (1): 13-7. 10181048
31. Suzuki Y, Araie M, Yumita A, Yamamoto T,. Effect of cyclocryotherapy and transscleral laser cyclophotocoagulation in refractory glaucoma. Japanese Journal of Clinical Ophthalmology 1989; 43 (6): 1021-5. 10181050
32. Tzamalis A, Pham DT, Wirbelauer C,. Diode laser cyclophotocoagulation versus cyclocryotherapy in the treatment of refractory glaucoma. European Journal of Ophthalmology 2011; 21 (5): 589-96. 10181052
33. Walland MJ,. Diode laser cyclophotocoagulation: dose-standardized therapy in end-stage glaucoma. Australian and New Zealand Journal of Ophthalmology 1998; 26 (2): 135-9. 10181054
34. Wei Z, Guohua Y, Junzhong M,. Long-term results of diode versus Nd:YAG contact transscleral laser cyclophotocoagulation for refractory glaucoma. Lasers and Light in Ophthalmology 1999; 9 (1): 29-35. 10181056
35. Xu S, Wang Y, Su G,. Evaluation of surgical effectiveness for neovascular glaucoma. Chinese Ophthalmic Research 2007; 25 (9): 707-9. 10181058
36. Yildirim N, Yalvac IS, Sahin A, Ozer A, Bozca T,. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. Journal of Glaucoma 2009; 18 (3): 192-6. 10181060
37. Yu JY, Kahook MY, Lathrop KL, Neocker RJ,. The effect of probe placement and type of visoelastic material on endoscopic cyclophotocoagulation laser energy transmission. Ophthalmic Surgery, Lasers and Imaging 2008; 39 (2): 133-6. 10181062
38. Zhang B,. Contrast of surgical effect of two different operations for neovascular glaucoma. International Journal of Ophthalmology 2010; 10 (4): 671-3. 10181064
39. Zweifach E, Wilensky J, Hillman D, Quinonse R, Gemperil A,. A prospective randomized trial of diode and Nd:YAG lasers in treating glaucoma. Investigative Ophthalmology and Visual Science 1997; Vol. 38: ARVO E-Abstract 844. 10181066
40. NCT01774227,. The pops-titration versus the slow-coagulation cyclophotocoagulation in treatment of refractory glaucoma. clinicaltrials.gov/ct2/show/NCT01774227 (first received 23 January 2013). 10181068
41. NCT02691455,. The AGS second aqueous shunt implant vs. transscleral cyclophotocoagulation treatment study (ASSISTS). clinicaltrials.gov/ct2/show/NCT02691455 (first received 25 February 2016). 10181070
42. NCT02875158,. Cyclophotocoagulation in glaucoma. clinicaltrials.gov/ct2/show/NCT02875158 (first received 23 August 2016). 10181072
43. Ansari E, Gandhewer J,. Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma. Eye 2007; 21 (7): 936-40.
44. Beckman H, Kinoshita A, Rota AN, Sugar HS,. Transscleral ruby laser irradiation of the ciliary body in the treatment of intractable glaucoma. Transactions of the American Academy of Ophthalmology and Otolaryngology 1972; 76 (2): 423-36.
45. Beckman H, Sugar HS,. Neodymium laser cyclocoagulation. Archives of Ophthalmology 1973; 90 (1): 27-8.
46. Bietti G,. Surgical intervention of the ciliary body; new trends for the relief of glaucoma. Journal of the American Medical Association 1950; 142 (12): 889-97.
47. Bloom PA, Tsai JC, Sharma K, Miller MH, Rice NS, Hitchings RA, et al., Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology 1997; 104 (9): 1508-19.
48. Burr J, Azuara-Blanco A, Avenell A, Tuulonen A,. Medical versus surgical interventions for open angle glaucoma. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD004399.pub3 ]
49. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. American Journal of Ophthalmology 1998; 126 (4): 498-505.
50. Coleman DJ, Lizzi FL, Driller J, Rosado AL, Burgess SE, Torpey JH, et al., Therapeutic ultrasound in the treatment of glaucoma. II. Clinical applications. Ophthalmology 1985; 92 (3): 347-53.
51. Coleman AL, Miglior S,. Risk factors for glaucoma onset and progression. Survey of Ophthalmology 2008; 53 (6 Suppl): S3-10.
52. Coleman AL,. Advances in glaucoma treatment and management: surgery. Investigative Ophthalmology and Visual Science 2012; 53 (5): 2491-4.
53. Eldaly M, Bunce C, ElSheikha O, Wormald R,. Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD007059.pub2 ]
54. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ,. The definition and classification of glaucoma in prevalence surveys. British Journal of Ophthalmology 2002; 86 (2): 238-42.
55. Friedman DS, Wolfs RC, O'Colmain BJ, Klein BE, Taylor HR, West S, et al., Prevalence of open-angle glaucoma among adults in the United States. Archives of Ophthalmology 2004; 122 (4): 532-8.
56. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J,. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006; 94 (2): 130-6.
57. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al., The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Archives of Ophthalmology 2002; 120 (6): 714-20.
58. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 6 December 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
59. He M, Foster PJ, Ge J, Huang W, Zheng Y, Friedman DS, et al., Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou. Investigative Ophthalmology and Visual Science 2006; 47 (7): 2782-8.
60. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al., Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology 2002; 120 (10): 1268-79.
61. Higgins JPT, Deeks JJ, Altman DG, (editors),. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.training.cochrane.org/handbook.
62. Higgins JPT, Altman DG, Sterne JAC (editors),. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.
63. Landers J, Goldberg I, Graham SL,. Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma. Clinical and Experimental Ophthalmology 2002; 30 (4): 242-7.
64. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, et al., Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Archives of Ophthalmology 2003; 121 (1): 48-56.
65. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, et al., Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108 (11): 1943-53.
66. Lin S,. Endoscopic cyclophotocoagulation. British Journal of Ophthalmology 2002; 86 (12): 1434-8.
67. Lin P, Wollstein G, Glavas IP, Schuman JS,. Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation. Long-term outcome. Ophthalmology 2004; 111 (11): 2137-43.
68. Liu GJ, Mizukawa A, Okisaka S,. Mechanism of intraocular pressure decrease after contact transscleral continuous-wave Nd:YAG laser cyclophotocoagulation. Ophthalmic Research 1994; 26 (2): 65-79.
69. Martin KR, Broadway DC,. Cyclodiode laser therapy for painful, blind glaucomatous eyes. British Journal of Ophthalmology 2001; 85 (4): 474-6.
70. Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN,. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. American Journal of Ophthalmology 2003; 136 (5): 805-13.
71. Minckler D, Vedula SS, Li T, Mathew M, Ayyala R, Francis B,. Aqueous shunts for glaucoma. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD004918.pub2 ]
72. Mistlberger A, Liebmann J, Tschiderer H, Ritch R, Ruckhofer J, Grabner G,. Diode laser transscleral cyclophotocoagulation for refractory glaucoma. Journal of Glaucoma 2001; 10 (4): 288-93.
73. Pan Y, Varma P,. Natural history of glaucoma. Indian Journal of Ophthalmology 2011; 59 (Suppl 1): S19-23.
74. Pastor SA, Singh K, Lee DA, Juzych MS, Lin SC, Netland PA, et al., Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology 2001; 108 (11): 2130-8.
75. Prum BE Jr, Rosenberg LF, Gedde SJ, Mansberger SL, Stein JD, Moroi SE, et al., Primary Open-Angle Glaucoma Preferred Practice Pattern Guidelines (2015). Ophthalmology 2016; 123 (1): P41-111.
76. Quigley HA,. Number of people with glaucoma worldwide. British Journal of Ophthalmology 1996; 80 (5): 389-93.
77. Quigley HA, Broman AT,. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006; 90 (3): 262-7.
78. Quigley HA,. Glaucoma. Lancet 2011; 377 (9774): 1367-77.
79. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
80. Sarkisian SR Jr,. Tube shunt complications and their prevention. Current Opinion in Ophthalmology 2009; 20 (2): 126-30.
81. Shields MB,. Cyclodestructive surgery for glaucoma: past, present, and future. Transactions of the American Ophthalmological Society 1985; 83: 285-303.
82. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY,. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121 (11): 2081-90.
83. Topouzis F, Yu F, Coleman AL,. Factors associated with elevated rates of adverse outcomes after cyclodestructive procedures versus drainage device procedures. Ophthalmology 1998; 105 (12): 2276-81.
84. Turkoski BB,. Glaucoma and glaucoma medications. Orthopaedic Nursing 2012; 31 (1): 37-41.
85. Van Rens GH, Arkell SM, Charlton W, Doesburg W,. Primary angle-closure glaucoma among Alaskan Eskimos. Documenta Ophthalmologica 1988; 70 (2-3): 265-76.
86. VanVeldhuisen PC, Ederer F, Gaasterland DE, Sullivan EK, Beck A, Prum BE Jr, et al., The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. American Journal of Ophthalmology 2000; 130 (4): 429-40.
87. Vass C, Hirn C, Syncha T, Findl O, Sacu S, Bauer P, et al., Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003167.pub3 ]
88. Vogt A,. Attempts to decrease intraocular pressure by means of diathermy damage to the ciliary body (cyclodiathermy) [Versuche zur intraokularen druckherabsetzung mittelst diathermieschädigung des corpus ciliare (Zyklodiathermiestichelung)]. Klinische Monatsblätter für Augenheilkunde 1936; 97: 672-3.
89. Weinreb RN, Aung T, Medeiros FA,. The pathophysiology and treatment of glaucoma: a review. JAMA 2014; 311 (18): 1901-11.
90. Chen MF, Kim CH, Coleman A,. Cyclodestructive procedures for refractory glaucoma. Cochrane Database of Systematic Reviews 2016, Issue 6. [DOI: 10.1002/14651858.CD012223 ]